All Type of News
MFDS constructs support system for Korean pharmas to enter international market using position as PIC/S member
The Ministry of Food and Drug Safety(MFDS) will construct a support system of Korean pharmaceutical companies to enter the overseas market by using the position as a PIC/S member.
According to the MFDS, ratings of Ko...
MOHW starts study for Public Pharmaceutical Company Control Tower to supply and control national essential drugs
It seems a study will be conducted to check possibility of having a control tower for the National Essential Pharmaceutical Product and public pharmaceutical companies.
Even at a recent confirmation hearing, Neung-Ho...
Japanese pharmas earn 77 out of selling KRW 1,000
Japanese pharmaceutical companies were observed to generate KRW 77 profits by selling products(including goods and merchandises) worth of KRW 1,000 in the Korean market.
Yakup Shinmoon(www.yakup.com) analyzed 2016 au...
MFDS’s plan to create GMP evaluation system meeting international standards, such as PIC/s
In order to establish a GMP manufacturing facility control system that meets the international standards, such as PIC/s, the Ministry of Food and Drug Safety(MFDS) will prepare a new GMP onsite system from the next ye...
MFDS raises transparency of approval and evaluation for drugs and biologics
The Ministry of Food and Drug Safety(MFDS) will adopt and run the ‘electronic recording system for civil affairs’ to raise transparency of the drug and biologic approval evaluation process.
The MFDS announced to cond...
Health-related government tasks unveiled
The government suggested 70% for the National Health Insurance coverage by 2020 as a government project. It will also set up the role of primary medical institute and large hospital and strengthen medical publicity by...
No exception in using name similar to drug or substance
A legal interpretation was made that there was no exception in using a name similar to a name of drug or substance unless it is a pharmaceutical manufacturer, such as pharmaceutical company.
The Ministry of Governmen...
Employees at Korean branches of Japanese pharma earn KRW 74 million per employee a year
It was observed employees working at a Korean branch of multinational Japanese pharmaceutical company earns KRW 74 million per employee a year on average, and annual wages of an employee at Takeda Pharmaceuticals Kore...
Japanese pharmas’ rapid growth in Korean pharmaceutical market
Japanese multinational pharmaceutical companies branching in Korea were analyzed to record excellent sales performances last year.
Yakup Shinmoon(www.yakup.com) analyzed 2016 audit reports turned in by Korean branche...
“352 Korean clinical trials were approved in 1st half of this year”
The Korea National Enterprise for Clinical Trials(Chairman Dong-Hyun Ji, KoNETC) revealed the pharmaceutical clinical trial registration status in the 1st half of 2017 at ClinicalTrials.gov, the world’s largest clinic...
